Port-A-Cath insertions in acute leukaemia and childhood malignancies

Amos H P Loh1, Chan-Hon Chui

  • 1Department of Paediatric Surgery, KK Women's and Children's Hospital, Singapore. aloh@alumni.nus.edu.sg

Insights

Port-A-Cath insertions in pediatric cancer patients show minimal complications, even in those with leukemia. Catheter-related bloodstream infections (CRBSIs) were infrequent, with Gram-negative organisms increasingly noted.

Area of Science:

  • Pediatric Oncology
  • Medical Devices
  • Infectious Diseases

Background:

  • Port-A-Cath (implantable port) devices are crucial for long-term venous access in pediatric cancer patients.
  • Catheter-related complications, particularly infections, can significantly impact patient outcomes and treatment continuity.

Purpose of the Study:

  • To determine the incidence and profile of complications associated with Port-A-Cath insertions in pediatric cancer patients.
  • To identify predictive factors for infection-related port removals in this population.

Main Methods:

  • Retrospective case series analyzing 175 Port-A-Cath insertions over 75,000 days (2002-2004).
  • Incidence of catheter-related bloodstream infections (CRBSIs) and other complications were compared between acute leukemia and other malignancy subgroups.
  • Analysis of factors associated with CRBSI-related port removals.

Main Results:

  • An overall CRBSI rate of 0.44 episodes per 1,000 catheter days was observed (18.9% of cases).
  • Complication rates were similar between acute leukemia and other malignancy groups, despite differences in preoperative platelet counts.
  • Staphylococcus epidermidis and Klebsiella spp. were the most common pathogens isolated from infected ports.

Conclusions:

  • Port-A-Cath insertions are associated with minimal complications in pediatric cancer patients, including those who are thrombocytopenic.
  • The increasing prevalence of Gram-negative organisms in CRBSIs reflects evolving trends in nosocomial infections.
Abstract